Status:
COMPLETED
Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Tobacco Product Beliefs and Use
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food \& Drug Admin...
Eligibility Criteria
Inclusion
- Adults (age 21 and over) who are current established cigarettes smokers (i.e., smoked 100 cigarettes in their lifetime and now smoke every day or somedays), based in the US, members of Ipsos' KnowledgePanel, and have chosen to complete their research panel surveys in English
Exclusion
- Panel participants who do not meet the criteria outlined above will be excluded.
Key Trial Info
Start Date :
April 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2025
Estimated Enrollment :
1257 Patients enrolled
Trial Details
Trial ID
NCT06927700
Start Date
April 24 2025
End Date
May 4 2025
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers Institute for Nicotine & Tobacco Studies
New Brunswick, New Jersey, United States, 08901